Health Minister Launches Free HPV Vaccination Campaign to Protect Girls from Cervical Cancer

Introduction

On 8 October 2025, Ghana’s Minister for Health, Kwabena Mintah Akandoh, officially opened a nationwide free HPV vaccination advertising campaign. The initiative, part of President John Mahama’s “Free Primary Health Care” agenda, aims to immunise 2.4 million girls aged 9–14 against the Human Papillomavirus (HPV), the leading cause of cervical cancer. This article explains the campaign’s scope, the science behind the Gardasil 4 vaccine, and practical steps parents can take to ensure their daughters receive the protection they deserve.

Analysis

Why HPV Matters in Ghana

Every year Ghana records approximately 3,000 new cases of cervical cancer and loses around 2,000 women to the disease. Cervical cancer is almost exclusively linked to persistent infection with high‑risk HPV strains. By targeting the virus before exposure, vaccination can dramatically reduce the incidence of this preventable cancer.

Key Stakeholders and Partnerships

The campaign is supported by a coalition of international and local organisations, including:

• World Health Organization (WHO)
• U.S. Food and Drug Administration (FDA)
• UNICEF
• Gavi, the Vaccine Alliance
• USAID, CDC, and PATH
• Ghana Health Service (GHS)

These partners provide technical expertise, funding, and logistical support, ensuring that the vaccine reaches even the most remote districts.

Implementation Strategy

The five‑day advertising drive covers all 16 regions of Ghana. Communication channels include radio, television, social media, community gatherings, and school‑based outreach. The vaccine will be administered primarily through school health programs and community health workers, guaranteeing that eligible girls are identified and vaccinated regardless of socioeconomic status.

Summary

Ghana’s free HPV vaccination campaign represents a historic public‑health milestone. By delivering the WHO‑ and FDA‑approved Gardasil 4 vaccine at no cost, the government aims to eradicate cervical cancer as a leading cause of female mortality. The initiative underscores the country’s commitment to health equity, preventive care, and the empowerment of women.

Key Points

Practical Advice

For Parents and Guardians

1. Verify eligibility: Ensure your daughter is between 9 and 14 years old.
2. Locate vaccination sites: Contact your local district health office or school nurse for the nearest vaccination day.
3. Schedule the dose: Gardasil 4 requires two doses, spaced 6 months apart. Record the appointment date.
4. Prepare documentation: Bring a birth certificate or national ID to confirm age.
5. Address concerns: Discuss common myths—such as fertility impact—with a qualified health professional.
6. Follow‑up: Keep the vaccination card safe; it serves as proof for future school enrolment and health records.

For Schools and Community Leaders

• Coordinate with the Ministry of Health to receive vaccine supplies on schedule.
• Organise informational sessions for parents, using culturally appropriate messaging.
• Maintain accurate logs of vaccinated students to track coverage rates.
• Provide a safe, clean environment for vaccine administration, adhering to cold‑chain requirements.

Points of Caution

While the Gardasil 4 vaccine is safe for the target age group, certain precautions are recommended:

• Allergic reactions: Individuals with a known severe allergy to yeast or any vaccine component should consult a physician before vaccination.
• Pregnancy: The vaccine is not indicated for pregnant women; however, it can be administered before pregnancy.
• Medical history: Children with compromised immune systems should be evaluated by a healthcare provider to determine the optimal vaccination schedule.

Any adverse event must be reported to the Ghana Food and Drugs Authority (FDA) through the national pharmacovigilance system.

Comparison

Gardasil 4 vs. Other HPV Vaccines

Ghana’s choice of Gardasil 4 balances broad protection against both cancer‑causing (16, 18) and wart‑causing (6, 11) HPV strains while keeping procurement costs manageable.

Legal Implications

The HPV vaccination campaign complies with several legal frameworks:

• National Immunisation Policy (2023): Mandates free provision of WHO‑approved vaccines for eligible populations.
• Ghana Food and Drugs Authority (FDA) Regulations: Gardasil 4 is listed on the national register of approved medicines, confirming its safety and quality.
• Data Protection Act (2012): Personal data collected during vaccination (e.g., name, age) must be stored securely and used solely for health‑service purposes.
• International Agreements: Ghana’s participation in the WHO Immunization Programme and Gavi’s vaccine alliance obliges the country to meet reporting and safety standards.

Failure to adhere to these regulations could result in legal penalties for health facilities, including fines or suspension of vaccine supply.

Conclusion

Ghana’s free HPV vaccination advertising campaign marks a decisive step toward eliminating cervical cancer as a public‑health threat. By delivering the WHO‑approved Gardasil 4 vaccine to 2.4 million girls at no cost, the government not only protects women’s health but also advances gender equity in healthcare access. Parents, schools, and community leaders play critical roles in ensuring high coverage, while vigilant monitoring safeguards safety and compliance. If the campaign achieves its targets, Ghana could serve as a model for other low‑ and middle‑income countries seeking to eradicate HPV‑related disease.

FAQ